Back to the complete issue
Wednesday, 27 November 2019

EFG-led Rx Healthcare confirms closing Egyptian meds producer United Pharma acquisition

M&A WATCH- Rx Healthcare confirms closing United Pharma acquisition: EFG Hermes’ Rx Healthcare Fund has confirmed media reportst that it has acquired a majority stake in meds producer United Pharma, according to an emailed statement (pdf). Rx carried out the acquisition through Nutritius Investment Holdings, a special purpose vehicle established for the acquisition, the statement reads. “The transaction attracted significant interest from prominent Egyptian and Gulf investors, with proceeds being used to expand the company’s product offering to cover generic categories in underserved therapeutic areas and ramp up production for IV products.” Neither the size of the stake nor the value of the transaction were disclosed, but previous press reports had indicated Rx acquired an 80% stake for somewhere around EGP 360 mn.

Advisors: Zaki Hashem & Partners acted as legal counsel to Rx Healthcare, while auditing firm Mazars Egypt acted as buy-side financial advisor. ARC Capital was the sell-side financial advisor, and our friends at ALC were legal counsel to the sellers.

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2021 Enterprise Ventures LLC.